| Proton pump inhibitors may contribute to progression or development of chronic obstructive pulmonary disease—a sequence symmetry analysis approach JL Janetzki, MJ Sykes, MB Ward, NL Pratt Journal of Clinical Pharmacy and Therapeutics 46 (6), 1687-1694, 2021 | 9 | 2021 |
| Application of an integrative drug safety model for detection of adverse drug events associated with inhibition of glutathione peroxidase 1 in chronic obstructive pulmonary disease JL Janetzki, NL Pratt, MB Ward, MJ Sykes Pharmaceutical Research 40 (6), 1553-1568, 2023 | 2 | 2023 |
| Exploring consumers’ perspective of community pharmacists delivering COVID-19 vaccinations: an Australian pilot study TNT Bui, JL Janetzki, WC Chai, V Suppiah International Journal of Pharmacy Practice 31 (3), 337-340, 2023 | 1 | 2023 |
| Innovations in pharmacovigilance studies of medicines in older people LM Kalisch Ellett, JL Janetzki, R Lim, TL Laba, NL Pratt British Journal of Clinical Pharmacology, 2024 | | 2024 |
| Understanding Australian Pharmacists’ Perceptions on the Utilisation of Oral 5-HT3 Antagonists as Pharmacist-Only Anti-Emetics in Comparison to Oral D2 Antagonists A Hendry, J Janetzki, WC Chai Journal of Pharmacy Practice, 08971900241236379, 2024 | | 2024 |
| A Digitally Enabled, Pharmacist service to detecT medicine harms in residential aged care (nursing home)(ADEPT): protocol for a feasibility study MS Boord, P Brown, J Soriano, T Meola, D Dumuid, R Milte, ... BMJ open 14 (2), e080148, 2024 | | 2024 |
| Chronic Obstructive Pulmonary Disease Adverse Event Signals Associated with Potential Inhibitors of Glutathione Peroxidase 1: A Sequence Symmetry Analysis JL Janetzki, MJ Sykes, MB Ward, NL Pratt Drug Safety 47 (1), 59-70, 2024 | | 2024 |
| Risk management: The importance and skill of saying'no' J Janetzki AJP: The Australian Journal of Pharmacy 104 (1234), 52-55, 2023 | | 2023 |
| Risk of aortic aneurysm or dissection following exposure to fluoroquinolone antibiotics JL Janetzki, JH Kim, JA Lee, SC You, NL Pratt | | |
| Modeling Decisions and Heterogeneity in Defining Aortic Diseases: Implications for Observational Studies and Phenotype Characterization E Minty, J Janetzki, J Gilbert, JH Kim, JA Lee, E Ross, N Pratt, G Rao, ... Age 18, 64, 0 | | |
